Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
China Resources Pharmaceutical (03320.HK) Subsidiary Tasly Pharmaceutical (600535.SH) 1Q Net Profit RMB365M Up 9.8% YoY
Recommend 3 Positive 3 Negative 1 |
||||
|
||||
|
China Resources Pharmaceutical (03320.HK) announced that its subsidiary Tasly Pharmaceutical (600535.SH) released its first-quarter report. Revenue amounted to RMB2.165 billion, representing a YoY increase of 5.3%. Net profit reached RMB365 million, up 9.8% YoY. (de/d) Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
